Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade
Glucose and H 2 O 2 dual-sensitive nanogels for enhanced glucose-responsive insulin delivery
Mission & Brand Positioning ZeGen uses slogans reflecting a collaborative and innovation-driven outlook such as a Unlocking Potential, Together a and actively positions itself as committed to providing globala standard healthcare solutions through quality and innovation
MontoroAObradorEMistryDForteGIBravatVMinafraLet alChapter 11: radioprotectors, radiomitigators and radiosensitizers
Access continues, pauses, or ends based on subscription terms and account status rather than on a visit schedule
